Research Article
Serum Markers in Rheumatoid Arthritis: A Longitudinal Study of Patients Undergoing Infliximab Treatment
Table 2
Summary of the RA patient cohort data. Age and gender distribution and mean pharmacological doses.
| | Variable | |
| | Number of patients | 39 | | Mean age ± SD (range) | 53 ± 12 (21–74) | | Gender ratio (F : M1) | 24 : 15 | | RA duration ± SD (range) | 11 ± 8 (1–29) | | RF-positive (/%) | 28/72 | | Anti-CCP positive (/%) | 31/80 | | Mean methotrexate dose ± SD (range) | 11 ± 5 (2.5–20) | | Mean infliximab dose ± SD (range) | 264 ± 58 (200–400) | | Mean prednisolone dose ± SD (range) | 4 ± 4 (0–10) |
|
|
Female to male ratio.
|
